跳至主要内容
临床试验/NCT02323308
NCT02323308已完成不适用

Study of Immunological, Virological, Serological Characteristics of HIV+ Patients Harboring Isolated Anti-HBc Profile and Response to Hepatitis B Vaccination

ANRS, Emerging Infectious Diseases1 个研究点 分布在 1 个国家目标入组 55 人开始时间: 2010年12月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
55
试验地点
1
主要终点
Average titers of anti-HBs Ab

研究概览

简要总结

The aim of study is to describe the clinical, immunological, serological, virological and therapeutic characteristics of HIV+ patients harboring isolated anti-HBc profile and to assess the response to vaccination in these patients.

研究设计

研究类型
Observational
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • HIV+ adults patients
  • negative HBsAg
  • negative a-HBs Ab
  • positive HBc Ab
  • without HBV - vaccination
  • CD4 cell above 200 /mm3
  • HIV viral load below 50 copies/mL

排除标准

  • positive HBs antigenemia in the past
  • transaminitis above fivefold upper normal limit
  • PT<50% or Platelet <50 000/mm3
  • ongoing opportunistic infection
  • ongoing or recent systemic corticoid or immunomodulatory therapy, splenectomy, pregnancy, contra-indication to intramuscular injection, familial history of neurological disease.

结局指标

主要结局

Average titers of anti-HBs Ab

时间窗: at 4 weeks, 28 weeks and 18 months after the first vaccination HBV

Analysis of B-cell phenotype and maturation

时间窗: at baseline and at week 28

Evaluation of immunological, virological and serological characteristics associated to "anti-HBc isolated" profile

时间窗: at Day 0, inclusion visite

次要结局

  • Detection of IgG+ memory B cells specific for HBcAg or HBs Ag(at baseline and 28 weeks after the first dose HBV vaccin)
  • Number of patients with HBsAb titers as protective titer>10 IU/L(at 4 weeks,28 weeks and 18 month after the first dose HBV vaccin)
  • - Detection of HBV preS2 and S-specific T cells(at day 0 and week 28)

研究者

申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验